Mononuclear complexes
[Pt(ppy)(S∧S)] (1a, S∧S = O,O′-di(cyclohexyl)dithiophosphate
(ctp); 2a, S∧S = O,O′-di(butyl)dithiophosphate (btp))
and [Pt(bzq)(S∧S)] (1b, S∧S = ctp; 2b, S∧S = btp) have been
prepared by the reaction of precursor complexes [Pt(C∧N)Cl(dmso)], C∧N = deprotonated form of 2-phenylpyrdine
(ppy) and 7,8-benzoquinoline (bzq), and potassium salt of S∧S ligands. All complexes were characterized by NMR spectroscopy,
and the structure of 2b was further identified by single
crystal X-ray determination. Although the complexes are not luminescent
in solution at ambient temperature, they become strong emissive materials
(bright green) in solid state (at room temperature) with high quantum
yields and long lifetimes in the microsecond domain. In frozen glass
state or at low temperature (solid state), these complexes become
better emissive in relation to room temperature. UV–vis spectra,
supported by TD-DFT calculations, indicate that 1ILCT (intraligand
charge transfer) predominates over the other transitions (L = C∧N cyclometalated ligand). Accordingly, 1 and 2 exhibit structured emission bands which display
a large involvement of 3LCCT (ligand-centered charge transfer)
with lower contribution of 3MLCT (metal to ligand charge
transfer) transition in the excited states. Also, biological activities
of 1 and 2 were evaluated against three
human cancer cell lines including A549 (human lung cancer), SKOV3
(human ovarian cancer), and MCF-7 (human breast cancer). 2a presented an effective potent cytotoxic activity regarding to the
cell lines. The cellular localization of 1a and 2a in MCF-7 human cells was investigated by fluorescence microscopy.